Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Cobalt launched Cobalt Autonomous Pentest, a new offering designed to enable continuous offensive security testing across entire application portfolios.
iMDx's GraftAssure assay demonstrated efficacy in guiding treatment decisions for kidney transplant patients using felzartamab, a CD38-targeted therapy, as published in The Lancet Regional Health – Europe on July 23, 2026.
